ON-TARGETplus Human ANKFY1 siRNA 5nmol

The University of Nebraska Medical Center (UNMC), a state agency of Nebraska, awarded a purchase order (PO No. 4800193614) to Horizon Discovery Biosciences Ltd, located in Chicago, Illinois, on April 9, 2026. The contract is valued at $534.00 and covers delivery of one unit of ON-TARGETplus Human ANKFY1 small interfering ribonucleic acid (siRNA) 5 nanomol (material number L-013161-00-0005), a molecular biology research reagent. The performance period extends from the award date of April 9, 2026, through the scheduled delivery date of April 14, 2026.

Delivery is designated for UNMC Shipping and Receiving at 601 South Saddle Creek Road, Omaha, Nebraska 68106, with an unloading point identified as SC.DRC1.7028. The purchase order is governed by the Standard Terms of Purchase established by the University of Nebraska Board of Regents, with payment terms of Net upon Receipt of Goods and Invoice. Shipping terms are Free on Board (FOB) Destination, and the order qualifies for tax-exempt status under UNMC's tax exemption number 05-8905401. The vendor is required to acknowledge acceptance of the order within ten days and ensure all documentation includes the purchase order number.